SG

Sridhar Gorthi

Active Director Director DIN 00035824
DIN 00035824 First appointment Apr 2005 Primary industry Consumer Electronics & Durables
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 17 historical roles
Total affiliations 24 Since Apr 2005
Shareholding value •••• Premium profile

About Sridhar Gorthi

Data last updated:

Sridhar Gorthi is a Director at Exide Industries Limited (since 2022), Director at Piramal Pharma Limited (since 2022) and Director at Vesuvius India Ltd (since 2025), and holds 4 more current directorships. The companies operate in Consumer Electronics & Durables, Pharma and Machinery and Equipment. The 5 current companies with reported revenue have a combined latest revenue of ₹29,158 Cr; the largest is Exide Industries Limited at ₹18,096 Cr (FY 2026). Earlier, Sridhar Gorthi was a Director at Hathway Cable And Datacom Limited (2009–2024) and Director at Glenmark Pharmaceuticals Limited (2005–2024) and 15 more.

DIN 00035824
Primary Designation Director
Industry Consumer Electronics & Durables
First Appointment 26 Apr 2005
Oldest Company Age 79 yrs
Largest company Exide Industries Limited · ₹18,096 Cr (FY 2026)
Combined revenue ₹29,158 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Exide Industries Limited L31402WB1947PLC014919
Director29 Jul 20221947₹18,096 Cr (FY 2026)Active
Piramal Pharma Limited L24297MH2020PLC338592
Director30 Mar 20222020₹9,082 Cr (FY 2026)Active
Vesuvius India Ltd L26933WB1991PLC052968
Director24 Sep 20251991₹1,638 Cr (FY 2023)Active
Nominee Director19 Oct 20242023₹341 Cr (FY 2025)Active
Gateway Securities Private Limited U55101MH1992PTC069789
Additional Director07 May 20241992₹1.7 Lakh (FY 2025)Active
Designated Partner29 Apr 20212021Active
Designated Partner07 Jan 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hathway Cable And Datacom Limited L64204MH1959PLC011421
Director10 Sep 20091959₹2,146 Cr (FY 2025)Active
Glenmark Pharmaceuticals Limited L24299MH1977PLC019982
Director26 Apr 20051977₹17,443 Cr (FY 2026)Active
Alivus Life Sciences Limited L74900PN2011PLC139963
Director30 Oct 20202011₹2,421 Cr (FY 2025)Active
Belgaum Wind Farms Private Limited U40108KA2007PTC042089
Director14 Mar 20072007₹11.66 Cr (FY 2025)Active
Director01 Mar 20062006Active
Brv India Advisors Private Limited U67190MH2007PTC171254
Director01 Jun 20072007Strike Off
Director19 May 20082008Strike Off
Hansen Systems Private Limited U72502PN2015PTC166405
Director17 Jun 20152015₹107 Cr (FY 2025)Active
Glenmark Generics Limited U24110MH1994PLC081597
Director Appointed In Casual Vacancy14 Aug 20081994Amalgamated
Director08 Sep 20082008Strike Off
Director10 Jan 20102002Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Sridhar Gorthi

Directorship timeline

Open interactive timeline →
Sterling And Wilson Data Center Private Limited
Kshna Capital Advisors Llp
Glenmark Generics Limited
Piramal Pharma Limited
Premium access

Shareholding and investment profile for Sridhar Gorthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sridhar Gorthi

Sridhar Gorthi currently holds 7 directorships: Exide Industries Limited (Director, since 29 Jul 2022, revenue ₹18,096 Cr (FY 2026)); Piramal Pharma Limited (Director, since 30 Mar 2022, revenue ₹9,082 Cr (FY 2026)); Vesuvius India Ltd (Director, since 24 Sep 2025, revenue ₹1,638 Cr (FY 2023)); Sterling And Wilson Data Center Private Limited (Nominee Director, since 19 Oct 2024, revenue ₹341 Cr (FY 2025)); Gateway Securities Private Limited (Additional Director, since 07 May 2024, revenue ₹1.7 Lakh (FY 2025)); and 2 more.

Sridhar Gorthi was first appointed on 26 Apr 2005 as Director at Glenmark Pharmaceuticals Limited. The most recent appointment on record is 24 Sep 2025 at Vesuvius India Ltd.

The 5 current companies of Sridhar Gorthi that report revenue have a combined latest revenue of ₹29,158 Cr: Exide Industries Limited ₹18,096 Cr (FY 2026); Piramal Pharma Limited ₹9,082 Cr (FY 2026); Vesuvius India Ltd ₹1,638 Cr (FY 2023); Sterling And Wilson Data Center Private Limited ₹341 Cr (FY 2025); Gateway Securities Private Limited ₹1.7 Lakh (FY 2025).

Sridhar Gorthi held 17 earlier board appointments: Hathway Cable And Datacom Limited (Director, 10 Sep 2009 to 04 Aug 2024); Glenmark Pharmaceuticals Limited (Director, 26 Apr 2005 to 31 Mar 2024); Alivus Life Sciences Limited (Director, 30 Oct 2020 to 07 Mar 2024); Belgaum Wind Farms Private Limited (Director, 14 Mar 2007 to 18 Dec 2007); Insite India Advisors Private Limited (Director, 01 Mar 2006 to 12 Jul 2018); and 12 more.

The current boards of Sridhar Gorthi's companies include Avik Kumar Roy (Exide Industries Limited), Avik Kumar Roy (Exide Industries Limited), Jaidit Singh Brar (Exide Industries Limited), Jitendra Kumar Mohan Lal (Exide Industries Limited), Manoj Kumar Agarwal (Exide Industries Limited), Manoj Kumar Agarwal (Exide Industries Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available